NYSE:ISR Isoray (ISR) Stock Forecast, Price & News Add Compare Share Share Today's Range N/A50-Day Range$0.28▼$0.4252-Week Range N/AVolume145,000 shsAverage Volume290,697 shsMarket Capitalization$54.57 millionP/E RatioN/ADividend YieldN/APrice TargetN/A ProfileProfileChartCompetitorsEarningsFinancialsInsider TradesInstitutional OwnershipHeadlinesSEC FilingsSocial MediaProfileChartCompetitorsEarningsFinancialsInsider TradesInstitutional OwnershipHeadlinesSEC FilingsSocial Media About Isoray (NYSE:ISR) StockIsoRay, Inc. is a medical technology company, which engages in the development, manufacture, and sale of isotope-based medical products and devices. The firm focuses on the treatment of cancer and other malignant diseases. Its core product is Cesium-131, a radioisotope for the treatment of malignant tumors. The company was founded by Lance A. Bray in 1983 and is headquartered in Richland, WA.Read More Receive ISR Stock News and Ratings via Email Sign-up to receive the latest news and ratings for Isoray and its competitors with MarketBeat's FREE daily newsletter. Email Address ISR Stock News HeadlinesJune 2, 2023 | americanbankingnews.comIsoray (NYSE:ISR) Now Covered by Analysts at StockNews.comMay 26, 2023 | americanbankingnews.comIsoray (NYSE:ISR) Research Coverage Started at StockNews.comJune 9, 2023 | UNKNOWN (Ad)This Company Is Solving A Multi-Billion Dollar Problem!This Little Known NASDAQ Stock is Solving a Multi-Billion Dollar Problem!May 10, 2023 | americanbankingnews.comStockNews.com Initiates Coverage on Isoray (NYSE:ISR)April 24, 2023 | thestreet.comWhy IsoRay (ISR) Is Plunging TodayApril 23, 2023 | americanbankingnews.comIsoray (NYSE:ISR) Receives New Coverage from Analysts at StockNews.comApril 17, 2023 | americanbankingnews.comHead to Head Contrast: Quipt Home Medical (NASDAQ:QIPT) and Isoray (NYSE:ISR)April 16, 2023 | americanbankingnews.comIsoray (NYSE:ISR) Now Covered by StockNews.comJune 9, 2023 | Behind the Markets (Ad)[BREAKING] Pentagon to Spend Billions on "Living Missile"Air Force Magazine calls it "transformational." The Wall Street Journal calls it one of the Pentagon's "highest priorities." National Defense Magazine reports "Eye-popping budget" for it. This small company won the first contract to build them!April 8, 2023 | americanbankingnews.comIsoray (NYSE:ISR) Coverage Initiated at StockNews.comMarch 25, 2023 | americanbankingnews.comComparing Paragon 28 (NYSE:FNA) and Isoray (NYSE:ISR)March 16, 2023 | thestreet.comWhy IsoRay (ISR) Stock Is Surging TodayFebruary 16, 2023 | finance.yahoo.comIsoRay (ISR) Reports Q2 Loss, Misses Revenue EstimatesFebruary 16, 2023 | finance.yahoo.comPerspective Therapeutics (formerly known as Isoray, Inc.) Announces Financial Results for the Quarter ended December 31, 2022February 8, 2023 | finanznachrichten.deIsoray, Inc.: Isoray Inc. and Viewpoint Molecular Targeting Inc. Announce Name Change to Perspective Therapeutics Inc.February 7, 2023 | finance.yahoo.comIsoray Inc. and Viewpoint Molecular Targeting Inc. Announce Name Change to Perspective Therapeutics Inc.February 6, 2023 | finance.yahoo.comIsoray Completes Merger with Viewpoint Molecular Targeting to Advance New Treatment Paradigm in Targeted Precision Oncology MedicineJanuary 30, 2023 | benzinga.comIsoray Announces Results of Fiscal 2023 Annual Meeting of StockholdersJanuary 30, 2023 | finance.yahoo.comIsoray Announces Results of Fiscal 2023 Annual Meeting of StockholdersJanuary 14, 2023 | thestreet.comWhy IsoRay (ISR) Hit a Five-Year High Today (Update)January 12, 2023 | finance.yahoo.comIsoray Announces Adjournment of Annual Meeting of Stockholders to January 27, 2023December 14, 2022 | finance.yahoo.comIsoray Announces Adjournment of Annual Meeting of Stockholders to January 12, 2022December 14, 2022 | finance.yahoo.comAMENDED: Isoray Announces Adjournment of Annual Meeting of Stockholders to January 12, 2023December 6, 2022 | proactiveinvestors.comIsoray's merger with Viewpoint Molecular Targeting sets up big opportunity in 2023December 6, 2022 | proactiveinvestors.comIsoray releases Q1 financials as company looks ahead to merger with Viewpoint Molecular TargetingNovember 25, 2022 | finance.yahoo.comIsoray, Inc. (ISR) Stock Historical Prices & Data - Yahoo FinanceNovember 11, 2022 | finanznachrichten.deIsoray, Inc.: Isoray Announces First Quarter Fiscal 2023 Financial Results and Provides Update to Pending MergerSee More Headlines ISR Company Calendar Last Earnings11/10/2021Today6/09/2023Fiscal Year End6/30/2023Get Stock AlertsIndustry, Sector and Symbol Stock ExchangeNYSE Industry Surgical & medical instruments Sub-IndustryN/A SectorMedical Current SymbolNYSE:ISR CUSIPN/A CIK728387 Webisoray.com Phone(509) 375-1202Fax509-267-3670EmployeesN/AYear FoundedN/AProfitability EPS (Most Recent Fiscal Year)($0.07) Trailing P/E RatioN/A Forward P/E RatioN/A P/E GrowthN/ANet Income$-7,270,000.00 Net Margins-115.91% Pretax Margin-91.45% Return on Equity-17.12% Return on Assets-16.15% Debt Debt-to-Equity RatioN/A Current Ratio14.38 Quick Ratio13.99 Sales & Book Value Annual Sales$10.80 million Price / Sales0.00 Cash FlowN/A Price / Cash FlowN/A Book Value$0.43 per share Price / BookN/AMiscellaneous Outstanding Shares142,110,000Free Float138,674,000Market Cap$54.57 million OptionableNot Optionable Beta1.48 Key ExecutivesLori A. WoodsChief Executive Officer & DirectorJennifer StreeterChief Operating Officer & VP-Human ResourcesMark J. AustinCo-CFO, Secretary & Chief Accounting OfficerJonathan R. HuntCFO & Principal Financial OfficerWilliam A. CavanaghChief Research & Development OfficerKey CompetitorsIceCure MedicalNASDAQ:ICCMMinerva SurgicalNASDAQ:UTRSPAVmedNASDAQ:PAVMSensus HealthcareNASDAQ:SRTSGBSNYSE:GBSView All CompetitorsInsidersJonathan Robert HuntBought 32,200 shares on 12/5/2022Total: $12,236.00 ($0.38/share)Jonathan Robert HuntBought 53,204 shares on 12/1/2022Total: $20,217.52 ($0.38/share)Lori A WoodsBought 100,000 shares on 11/15/2022Total: $34,000.00 ($0.34/share)View All Insider Transactions ISR Stock - Frequently Asked Questions How were Isoray's earnings last quarter? Isoray, Inc. (NYSE:ISR) released its quarterly earnings data on Wednesday, November, 10th. The company reported ($0.02) earnings per share (EPS) for the quarter, missing analysts' consensus estimates of ($0.01) by $0.01. The firm had revenue of $2.56 million for the quarter, compared to the consensus estimate of $2.58 million. Isoray had a negative net margin of 115.91% and a negative trailing twelve-month return on equity of 17.12%. What is Isoray's stock symbol? Isoray trades on the New York Stock Exchange (NYSE) under the ticker symbol "ISR." How do I buy shares of Isoray? Shares of ISR stock can be purchased through any online brokerage account. Popular online brokerages with access to the U.S. stock market include WeBull, Vanguard Brokerage Services, TD Ameritrade, E*TRADE, Robinhood, Fidelity, and Charles Schwab. Compare Top Brokerages Here. How much money does Isoray make? Isoray (NYSE:ISR) has a market capitalization of $0.00 and generates $10.80 million in revenue each year. The company earns $-7,270,000.00 in net income (profit) each year or ($0.07) on an earnings per share basis. How can I contact Isoray? Isoray's mailing address is 350 HILLS STREET SUITE 106, RICHLAND WA, 99354. The official website for the company is isoray.com. The company can be reached via phone at (509) 375-1202, via email at dbabcock@isoray.com, or via fax at 509-267-3670. This page (NYSE:ISR) was last updated on 6/9/2023 by MarketBeat.com Staff Adding Choose a watchlist: Watchlist Adding You have already added five stocks to your watchlist. Upgrade to MarketBeat All Access to add more stocks to your watchlist. Adding Isoray, Inc. Please log in to your account or sign up in order to add this asset to your watchlist. Get 30 Days of MarketBeat All Access Free Sign up for MarketBeat All Access to gain access to MarketBeat's full suite of research tools: Best-in-Class Portfolio Monitoring View the latest news, buy/sell ratings, SEC filings and insider transactions for your stocks. Compare your portfolio performance to leading indices and get personalized stock ideas based on your portfolio. Stock Ideas and Recommendations Get daily stock ideas from top-performing Wall Street analysts. Get short term trading ideas from the MarketBeat Idea Engine. View which stocks are hot on social media with MarketBeat's trending stocks report. Advanced Stock Screeners and Research Tools Identify stocks that meet your criteria using seven unique stock screeners. See what's happening in the market right now with MarketBeat's real-time news feed. Export data to Excel for your own analysis. Start Your 30-Day Free Trial Sign in to your free account to enjoy these benefits In-depth profiles and analysis for 20,000 public companies. Real-time analyst ratings, insider transactions, earnings data, and more. Our daily ratings and market update email newsletter. Sign in to your free account to enjoy all that MarketBeat has to offer. Sign In Create Account Your Email Address: Your Password: or Sign in with Facebook Sign in with Google Forgot your password? Your Email Address: Choose a Password: Create My Account (Free) or Sign in with Facebook Sign in with Google By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.